PrescriberPoint is a Boston-based, AI-enabled point-of-care platform that supports clinicians at every step of the prescribing journey - from researching FDA-approved drug information to checking coverage and out-of-pocket costs, submitting prior authorizations, and enrolling patients in savings programs. Spun out of work with Eli Lilly and BCG, it consolidates fragmented prescribing resources for tens of thousands of medications into one portal, and in 2025 reached more than 5 million healthcare professionals - one of the largest active HCP networks in digital health.
Dan Cornwell is the founder and CEO of PrescriberPoint, a Boston-based, AI-enabled medication access platform that helps clinicians cut through the paperwork between writing a prescription and a patient actually getting their medicine. Spun out of Eli Lilly in partnership with BCG Digital Ventures, the company raised seed backing from an unusual coalition of would-be rivals - Lilly, Pfizer, Adobe and Mastercard. Before PrescriberPoint, Cornwell ran the nurse-staffing marketplace IntelyCare and advised companies on building disruptive businesses at BCG Digital Ventures. A Yale historian turned Wharton-trained operator, he keeps returning to the same problem: the messy gap between a good intention and a completed transaction.